Skip to content
lifestyle.getpetsavvy.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SK BIOSCIENCE
SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
July 2, 2026
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
March 18, 2026
SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union
February 26, 2026
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
February 3, 2026
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 29, 2026
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 23, 2026